Search
  1. Home
  2. Africa

3-in-one anti-AIDS pill in WHO pipeline

    JOHANNESBURG

    The World Health Organisation (WHO) could soon reveal the first details of its global strategy to bring low-cost HIV/AIDS drugs to 3 million people in developing countries by 2005.

    WHO officials in Geneva recently confirmed that the plan could also eventually include the endorsement of pills that combine three anti-HIV/AIDS drugs in a single dose.

    In a recent interview with the Washington Post newspaper, the director of the HIV/AIDS department at WHO, Paulo Teixeira, said: "If we have this regimen in fixed-dose combinations, it will be the best. I hope very soon we will have more and more fixed-dose combinations."

    The single-pill combinations, which are already being sold by a generic-drug manufacturer in India, are expected to offer huge benefits to about 80 percent of people living with HIV/AIDS in developing countries, by providing them with medication in an easy-to-use, low-cost form.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join